Related Experiment Video

Updated: Jun 18, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics

Ann B Sollinger1, Felicia C Goldstein, James J Lah

  • 1Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA. asollin@emory.edu

Parkinsonism & Related Disorders
|November 27, 2009
PubMed

Insights

Mild cognitive impairment (MCI) affects over half of Parkinson's disease (PD) patients, often impacting memory and executive function. Longer disease duration and gait issues are linked to cognitive decline in PD.

Area of Science:

  • Neurology
  • Neuroscience
  • Cognitive Science

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder impacting motor function.
  • Cognitive impairment is a common non-motor symptom in PD, affecting quality of life.
  • Mild cognitive impairment (MCI) represents an intermediate stage between normal cognition and dementia.

Purpose of the Study:

  • To identify risk factors for mild cognitive impairment (MCI) in Parkinson's disease (PD).
  • To describe the clinical characteristics of MCI in PD patients.
  • To explore potential predictors of cognitive changes in PD.

Main Methods:

  • Retrospective review of medical records for 72 non-demented PD patients.
  • Standardized neurological assessment including a comprehensive neuropsychological battery.
  • Comparison of cognitive status (cognitively normal vs. MCI) based on established criteria.

Main Results:

  • Over half (52.8%) of PD patients met criteria for MCI.
  • The most common MCI subtype was single-domain, affecting memory, executive function, visuospatial skills, or language.
  • MCI patients exhibited longer PD duration and higher scores on the postural instability and gait disorder subscale.

Conclusions:

  • MCI is prevalent in Parkinson's disease and associated with specific clinical features.
  • Disease duration and gait/balance impairments may indicate increased risk for cognitive decline.
  • Further research is needed to identify MCI subtypes and their progression to dementia in PD.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment05:58

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment

Published on: March 11, 2021

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...